These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4141669)

  • 1. [Proceedings: 131 I uptake by the thyroid after termination of antithyroid agent treatment].
    Ishii J
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):398. PubMed ID: 4141669
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of determination of early thyroidal 131-I uptake rate--relationship with 24-hour 131-I uptake rate].
    Nagataki S; Uchimura H; Irie M; Tsushima T; Masuyama H
    Horumon To Rinsho; 1972 Feb; 20(2):107-14. PubMed ID: 4112484
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of pre-operative drug treatment on the histological appearances and in-vitro 131I-uptake of human hyperplastic thyroid gland.
    Nicol AG; Young RJ; Elmslie WH; Harbitz TB; Michie W; Pegg CA; Beck JS
    J Pathol; 1973 Jan; 109(1):P8-9. PubMed ID: 4124217
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.
    Hales I; Stiel J; Reeve T; Heap T; Myhill J
    J Clin Endocrinol Metab; 1969 Jul; 29(7):998-1001. PubMed ID: 4183236
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
    Stege R
    Acta Chir Scand Suppl; 1980; 501():1-130. PubMed ID: 6163270
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thyrostatics].
    Herrmann J
    Med Klin; 1978 Aug; 73(32-33):1146-51. PubMed ID: 79978
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperthyroidism and iodine].
    Nagataki S; Uchimura H
    Nihon Rinsho; 1971 May; 29(5):1294-9. PubMed ID: 4103636
    [No Abstract]   [Full Text] [Related]  

  • 8. [Four-year follow-up of thyrotoxic patients treated with antithyroid drugs bases on thyroid suppressibility-Prognostic value of the 20-min 131-I thyroid uptake (author's transl)].
    Leclere J; Ueda M; Hartemann P; Maureira JJ; Mizrahi R; Zannetti A; Weyland M; Vaillant D
    Ann Endocrinol (Paris); 1980; 41(2):95-105. PubMed ID: 6162414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine distribution in thyroid tissue taken from hyperthyroid patients treated with Lugol's solution or carbimazole.
    Etling N
    Rev Eur Etud Clin Biol; 1971; 16(7):662-7. PubMed ID: 4107371
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of the thyroid iodide "trap" in man.
    Alexander WD; Harden RM; Shimmins J
    Recent Prog Horm Res; 1969; 25():423-46. PubMed ID: 4187243
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of thyroid function during and after treatment of thyrotoxicosis.
    McLarty DG; Alexander WD
    J Clin Pathol; 1975 Mar; 28(3):251-4. PubMed ID: 47343
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of a 30 year use of synthetic thyroid antagonists].
    Laroche C; Remy JM; Letellier P
    Therapie; 1974; 29(5):659-73. PubMed ID: 4142659
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.
    Alexander WD; McLarty DG; Robertson J; Shimmins J; Brownlie BE; Harden RM; Patel AR
    J Clin Endocrinol Metab; 1970 Apr; 30(4):540-3. PubMed ID: 4190916
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyroid suppressibility: follow-up for two years after antithyroid treatment.
    Lowry RC; Lowe D; Hadden DR; Montgomery DA; Weaver JA
    Br Med J; 1971 Apr; 2(5752):19-22. PubMed ID: 4101408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid suppression test as index of outcome of hyperthyroidism treated with antithyroid drugs.
    Cassidy CE
    Metabolism; 1970 Oct; 19(10):745-50. PubMed ID: 4096944
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of antithyroid medication on the effective half-life and uptake of 131-iodine following radioiodine therapy].
    Moka D; Voth E; Schicha H
    Nuklearmedizin; 1997 Apr; 36(3):87-92. PubMed ID: 9162907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thyroid gland autoantibodies in hyperthyroidism. Observations on the course of the diseases during antithyroid therapy].
    Krüskemper HL; Beisenherz W; Gillich KH
    Schweiz Med Wochenschr; 1970 Feb; 100(8):376-80. PubMed ID: 4111093
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug treatment in thyroid disease.
    Mills LC
    Semin Drug Treat; 1974; 3(4):377-402. PubMed ID: 4132535
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reduced antithyroid agents as a result of radioiodine therapy?].
    Sabri O; Büll U
    Nuklearmedizin; 1999; 38(4):3-6. PubMed ID: 10392372
    [No Abstract]   [Full Text] [Related]  

  • 20. [T-lymphocytes, the TRH-test and the suppression test in thyreostatically treated hyperthyroidism].
    Hackenberg K; Cohnen G; Wiermann H; Reinwein D; von zum Mühlen A
    Verh Dtsch Ges Inn Med; 1975; 81():1555-8. PubMed ID: 58495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.